Accessed 3/17/2022, Drenjancevic I, Pitha J
The material here is a research-grade lyophilized peptide vial documented for in vitro laboratory work, with no patient-directed preparation, prescription pathway, or dispensing framework attached
It is used topically, providing localized infection control and reducing systemic side effects
Every batch is independently third-party tested to 99.80% verified purity

Mold Immune Reactivity IgE: Cladosporium herbarum : 2.4 Penicillium chrysogen : 4.1 Remaining panel: negative IgG: Broad elevation across multiple molds (including Cladosporium, Aspergillus, Setomelanomma, Curvularia ) Clinical Interpretation of Findings Indicated: Strong mold-specific immune sensitization Intermediate Intervention: Immune Modulation and Neuroregulation Oral immunotherapy (1 5 drops over 5 weeks) L-theanine 200 mg three times daily Clinical Response: Substantial reduction in anxiety Improved cognitive clarity Improved emotional stability Escalation of Binding Therapy Cholestyramine introduced Clinical Response (2 months): Resolution of fatigue Resolution of pain Improved GI symptoms Reduced food intolerance Final Intervention: Glutathione IV glutathione titrated from 1000 mg 3000 mg over 6 weeks Clinical Response: Resolution of insomnia Outcome Neuropsychiatric symptoms resolved Systemic symptoms improved Sleep normalized Discussion Objective improvement may precede symptom resolution Early reductions in C4a and TGF-1 suggest physiologic improvement before full clinical recovery

About this article Cite this article Levy, S., Grau-Bov, X., Kim, I.V